cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Alvotech Sa
Current Price
$12.85
$0.07
(0.55%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
- -
52-Week High
52-Week High
14.04
52-Week Low
52-Week Low
5.2
Average Volume
Average Volume
0.13M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization - -
icon52-Week High14.04
icon52-Week Low5.2
iconAverage Volume0.13M
iconDividend Yield--
iconP/E Ratio--
What does the Alvotech Sa do?
N/A
Read More
News & Events about Alvotech Sa.
Globe Newswire
2days ago
Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair (omalizumab) in the European Economic Area, UK, Switzerland, Canada, Australia, and New Zealand Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
Globe Newswire
2days ago
Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair (omalizumab) in the European Economic Area, UK, Switzerland, Canada, Australia, and New Zealand REYKJAVIK, Iceland, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the ...
Globe Newswire
15days ago
AVT02 as Simlandi is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure Alvotech (NASDAQ: ALVO) and Bioventure, a wholly owned subsidiary of GlobalOne Healthcare Holding LLC (GHH), the healthcare division of Yas Holding LLC, today announced that the Saudi ...
Globe Newswire
15days ago
AVT02 as Simlandi is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure REYKJAVIK, Iceland and DUBAI, United Arab Emirates, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Bioventure, a wholly owned subsidiary of GlobalOne Healthcare Holding ...
Globe Newswire
16days ago
REYKJAVIK, Iceland, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private placement of approximately $137 million, at current ...
Frequently Asked Questions
Frequently Asked Questions
What is Alvotech Sa share price today?
plus_minus_icon
Can Indians buy Alvotech Sa shares?
plus_minus_icon
How can I buy Alvotech Sa shares from India?
plus_minus_icon
Can Fractional shares of Alvotech Sa be purchased?
plus_minus_icon
What are the documents required to start investing in Alvotech Sa stocks?
plus_minus_icon
What is today’s traded volume of Alvotech Sa?
plus_minus_icon
What is today’s market capitalisation of Alvotech Sa?
plus_minus_icon
What is the 52-Week High and Low Range of Alvotech Sa?
plus_minus_icon
What percentage is Alvotech Sa down from its 52-Week High?
plus_minus_icon
What percentage is Alvotech Sa up from its 52-Week Low?
plus_minus_icon
Current Price
$12.85
$0.07
(0.55%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00